1. Home
  2. ZH vs ARVN Comparison

ZH vs ARVN Comparison

Compare ZH & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZH
  • ARVN
  • Stock Information
  • Founded
  • ZH 2011
  • ARVN 2015
  • Country
  • ZH China
  • ARVN United States
  • Employees
  • ZH N/A
  • ARVN N/A
  • Industry
  • ZH Business Services
  • ARVN Biotechnology: Pharmaceutical Preparations
  • Sector
  • ZH Consumer Discretionary
  • ARVN Health Care
  • Exchange
  • ZH Nasdaq
  • ARVN Nasdaq
  • Market Cap
  • ZH 421.4M
  • ARVN 456.2M
  • IPO Year
  • ZH 2021
  • ARVN 2018
  • Fundamental
  • Price
  • ZH $5.16
  • ARVN $7.95
  • Analyst Decision
  • ZH Strong Buy
  • ARVN Buy
  • Analyst Count
  • ZH 1
  • ARVN 22
  • Target Price
  • ZH $4.70
  • ARVN $20.02
  • AVG Volume (30 Days)
  • ZH 385.3K
  • ARVN 1.3M
  • Earning Date
  • ZH 08-27-2025
  • ARVN 10-29-2025
  • Dividend Yield
  • ZH N/A
  • ARVN N/A
  • EPS Growth
  • ZH N/A
  • ARVN N/A
  • EPS
  • ZH 0.22
  • ARVN N/A
  • Revenue
  • ZH $439,821,184.00
  • ARVN $372,800,000.00
  • Revenue This Year
  • ZH N/A
  • ARVN $1.61
  • Revenue Next Year
  • ZH $6.47
  • ARVN N/A
  • P/E Ratio
  • ZH $23.61
  • ARVN N/A
  • Revenue Growth
  • ZH N/A
  • ARVN 299.57
  • 52 Week Low
  • ZH $3.13
  • ARVN $5.90
  • 52 Week High
  • ZH $6.32
  • ARVN $29.61
  • Technical
  • Relative Strength Index (RSI)
  • ZH 58.76
  • ARVN 58.47
  • Support Level
  • ZH $4.64
  • ARVN $7.51
  • Resistance Level
  • ZH $5.55
  • ARVN $7.89
  • Average True Range (ATR)
  • ZH 0.20
  • ARVN 0.34
  • MACD
  • ZH 0.01
  • ARVN -0.01
  • Stochastic Oscillator
  • ZH 57.14
  • ARVN 63.16

About ZH Zhihu Inc. (every two of each representing one ordinary share)

Zhihu Inc is predominantly engaged in the operation of one online content community and monetizes through paid membership services, advertising services, content-commerce solutions services, and vocational training in China. It generates revenues from Advertising services, Paid membership services, Content-commerce solutions, and Others. It derives all its revenues within China.

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

Share on Social Networks: